Acadia Pharmaceuticals Inc. (ACAD) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ACAD. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 2 institutions reported holding ACAD, with 1,036 shares worth $20,875 in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Versant Capital Management | 974 | $20K | INCREASED |
| Massmutual Private Wealth & Trust, Fsb | 62 | $1K | UNCHANGED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | EXERCISE | 14,292 | $255K | 2026-08-05 |
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | EXERCISE | 5,849 | $104K | 2026-08-05 |
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | SELL | 9,292 | $273K | 2026-08-05 |
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | SELL | 5,000 | $145K | 2026-08-05 |
| Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) | SELL | 5,849 | $170K | 2026-08-05 |
Full institutional holdings, insider history, and congressional trades for Acadia Pharmaceuticals Inc. on SentiSense.